BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1037379)

  • 1. [Endocrine effects of bromocryptin in patients with Parkinsonism].
    Barreca T; Gianrossi R; Gallamini A; Nizzo MC; Queirolo A
    Boll Soc Ital Biol Sper; 1976 Oct; 52(19):1564-7. PubMed ID: 1037379
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of Parkinson disease with Bromocriptine (CB 154 Sandoz) (author's transl)].
    Jacobides GB; Audibert A
    Ther Umsch; 1975 Jul; 32(7):469-71. PubMed ID: 1105868
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with the use of parlodel in the treatment of Parkinson patients].
    Stoliarova LG; Kadykov AS; Shvedkov VV; Pivovarova VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):219-22. PubMed ID: 3705825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Parkinson's disease with bromocriptine].
    Castaigne P; Laplane D; Bousser MG; Bories F
    Nouv Presse Med; 1976 Apr; 6(17):1482. PubMed ID: 1037400
    [No Abstract]   [Full Text] [Related]  

  • 5. [Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism].
    Kissel P; Andre JM; Jacquier A
    Nouv Presse Med; 1976 Jan; 5(4):210. PubMed ID: 1264671
    [No Abstract]   [Full Text] [Related]  

  • 6. Developments in the treatment of parkinsonism.
    Calne DB
    N Engl J Med; 1976 Dec; 295(25):1433-4. PubMed ID: 989886
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Bromocriptine in parkinsonism.
    Debono AG; Donaldson I; Marsden CD; Parkes JD
    Lancet; 1975 Nov; 2(7942):987-8. PubMed ID: 53479
    [No Abstract]   [Full Text] [Related]  

  • 8. Bromocriptine and lisuride in Parkinson disease.
    Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
    Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parkinsonian syndrome caused by carbon monoxide poisoning. Preliminary results of the treatment with bromocriptine].
    De Pooter MC; Leys D; Godefroy O; De Reuck J; Petit H
    Rev Neurol (Paris); 1991; 147(5):399-403. PubMed ID: 1853038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Bromocriptine in parkinsonism.
    Lees AJ; Shaw KM; Stern GM
    Lancet; 1975 Oct; 2(7937):709-10. PubMed ID: 52084
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical studies with bromocriptine in idiopathic parkinsonism.
    Teychenne PF; Kartzinel R; Perlow M; Pfeiffer R; Calne DB
    Trans Am Neurol Assoc; 1976; 101():302-4. PubMed ID: 1037483
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Growth-hormone response to bromocriptine in parkinsonism.
    Shaw KM; Lees AJ; Hayes S; Ross EJ; Stern GM; Thompson BD
    Lancet; 1976 Jan; 1(7952):194. PubMed ID: 54702
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.
    Serby M; Angrist B; Lieberman A
    Adv Biochem Psychopharmacol; 1980; 23():287-92. PubMed ID: 6104908
    [No Abstract]   [Full Text] [Related]  

  • 14. Lisuride in parkinsonism.
    Parkes JD; Schachter M; Marsden CD; Smith B; Wilson A
    Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful use of bromocriptine in the treatment of a patient with chronic portasystemic encephalopathy.
    Morgan MY; Jakobovits A; Elithorn A; James IM; Sherlock S
    N Engl J Med; 1977 Apr; 296(14):793-4. PubMed ID: 576493
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral lisuride in Parkinson's disease].
    Obeso JA; Luquin MR; Martínez Lage JM
    Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822
    [No Abstract]   [Full Text] [Related]  

  • 17. Bromocriptine in Parkinson disease.
    Lieberman AN; Goldstein M
    Pharmacol Rev; 1985 Jun; 37(2):217-27. PubMed ID: 3901046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bromocriptin in Parkinson's syndrome].
    Völler GW; Ulm G
    Med Welt; 1979 Dec; 30(51-52):1930-3. PubMed ID: 542110
    [No Abstract]   [Full Text] [Related]  

  • 19. Progressive supranuclear palsy: clinical features and response to treatment in 16 patients.
    Jackson JA; Jankovic J; Ford J
    Ann Neurol; 1983 Mar; 13(3):273-8. PubMed ID: 6847139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
    Klawans HL; Paleologos N
    Clin Neuropharmacol; 1986; 9(3):298-302. PubMed ID: 3719575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.